Published: October 16, 2020 | Updated: September 11, 2026
Male Infertility & Regenerative Medicine
Can Stem Cell Therapy Support
Sperm Function in Male Infertility?
Researchers continue to investigate whether stem cells may support spermatogenesis and testicular tissue repair in certain forms of male infertility. Scientific studies are exploring their potential role in reproductive health and tissue regeneration.
Evidence remains limited and evolving, and outcomes may vary depending on the underlying cause and severity of infertility. A comprehensive andrological and reproductive medicine evaluation is recommended before considering this investigational option.
Current Areas of Research
- Potential support for spermatogenesis (sperm production)
- Investigation into testicular tissue repair mechanisms
- Research on factors influencing sperm quality parameters
- Ongoing studies evaluating safety and clinical outcomes
Stem cell therapy for male infertility remains investigational. Eligibility should be determined through a detailed reproductive medicine and andrological assessment.
Key Takeaways
- 01. Definition of condition and scope:
Male infertility refers to the inability of a man to father a child due to low sperm count, poor sperm quality, or blockage in the reproductive system. - 02. Stem cell therapy concept:
The treatment uses adult mesenchymal stem cells (from bone marrow or adipose tissue) injected into the testicles to stimulate sperm production and improve fertility potential. - 03. Early reported outcomes:
Around 70–80% of treated men showed improved erection, 60–70% opted for a booster dose, and 80–90% reported significant enhancement in fertility parameters. - 04. Experimental status:
Stem cell therapy for male infertility is still in the experimental phase, with limited large-scale clinical trials and no guaranteed cure. - 05. Supplemental treatments and lifestyle:
Along with stem cell implantation, healthy habits—such as avoiding smoking, alcohol, and toxins, maintaining a healthy weight, and following conventional fertility care—are recommended.
Male infertility is the inability of a man to contribute to conception, and a male factor is identified in roughly 40–50% of couples experiencing infertility — comparable to the female-factor share covered on our Female Infertility page. It is most often due to problems with sperm production, sperm function, or a blockage somewhere in the delivery pathway — three mechanically distinct problems that require different diagnostic tests and, often, entirely different treatments.
At Viezec, we start by classifying male infertility into one of four categories — testicular (production) factors, obstructive factors, hormonal factors, or genetic factors — before any treatment, including stem cell therapy, is discussed. Current stem cell research in this area is concentrated almost entirely on one specific scenario: non-obstructive azoospermia (NOA), where the testes are not producing sperm due to impaired spermatogenesis, not because of a blockage. It is not studied as, and should not be marketed as, a general male fertility solution.
If your semen analysis already shows azoospermia or a very low count, the sections below explain what the evidence says, who may be a candidate, and what a realistic outcome looks like. If you haven’t had a full diagnostic work-up yet, start with Diagnosis below.
See our Infertility hub page for both male and female infertility pathways — since infertility involves both partners in a meaningful share of couples, many patients benefit from reviewing both pages together.
Male infertility linked to low sperm count, poor motility, or impaired testicular function is an area where regenerative medicine is increasingly being explored as a supportive approach. Viezec functions as a specialized stem cell clinic, where each patient first undergoes detailed diagnostic testing to identify the underlying cause of infertility before any stem cell-based intervention is considered.
Unlike clinics that offer a single fixed protocol, Viezec operates as a stem cell center built around individualized case review, connecting patients with an established stem cell provider network only after their clinical suitability is confirmed. This evaluation-first approach means treatment plans are shaped by each patient’s specific fertility diagnosis rather than generalized assumptions.
For patients weighing their options, questions around treatment cost and logistics are addressed directly through our pricing and travel FAQ, while clinical oversight is handled by a qualified doctor experienced in reproductive stem cell therapy. Viezec also coordinates with an accredited stem cell hospital in India to ensure procedures meet appropriate clinical and safety standards.
What causes male infertility?
Male infertility falls into one of four categories, and identifying which one applies determines whether stem cell research is even relevant to your case:
- Testicular (production) factors — non-obstructive azoospermia, impaired spermatogenesis, varicocele affecting sperm production, or damage from chemotherapy/radiation.
- Obstructive factors — a physical blockage in the vas deferens or epididymis (from infection, prior surgery such as vasectomy, or congenital absence of the vas deferens) that prevents sperm from being ejaculated despite normal production.
- Hormonal factors — low testosterone, elevated prolactin, or pituitary/hypothalamic disorders disrupting the signals needed for sperm production.
- Genetic factors — conditions such as Klinefelter syndrome (XXY) or Y-chromosome microdeletions that impair sperm production from birth.
- Lifestyle and environmental factors — smoking, heavy alcohol use, anabolic steroid use, heat exposure, and certain toxin exposures, which can reduce sperm count and quality without being the sole cause.
Why this distinction matters for treatment choice
Current stem cell and spermatogonial stem cell (SSC) research has focused almost entirely on non-obstructive azoospermia — cases where the testes themselves aren’t producing sperm. It has not been studied as a treatment for obstructive azoospermia, which is a mechanical problem usually corrected surgically or bypassed via ICSI/IVF, or for most hormonal causes, which are typically treated first with hormone therapy — often resolving the fertility issue without any regenerative approach. If your diagnosis points to an obstructive or hormonal cause, a stem cell consultation would not be the appropriate next step, and we’ll tell you this directly.
Related reading: How Stem Cell Therapy Works for the general mechanism, or jump to Diagnosis to see the tests used to confirm which category applies to you.
What are the symptoms of male infertility?
Like female infertility, male infertility often has no standalone symptom — many men only discover it through a semen analysis after a couple has been trying to conceive without success. That said, certain signs are worth raising with a doctor because they can point to an underlying cause:
- Changes in sexual function — difficulty with erection or ejaculation, or a marked drop in libido, can sometimes accompany hormonal causes.
- Pain, swelling, or a lump in the testicles — can indicate varicocele, infection, or a structural issue worth imaging.
- Changes in body characteristics — reduced facial or body hair, or breast tissue development, can suggest a hormonal imbalance (such as low testosterone).
- Recurrent respiratory infections alongside infertility — occasionally linked to specific genetic conditions affecting both systems.
What to do if you notice these signs
None of the above should lead directly to a stem cell therapy consultation. The correct next step is a semen analysis and hormonal work-up — see Diagnosis — because a stem cell-based approach is only relevant for one specific diagnosis: non-obstructive azoospermia confirmed through this testing, not for every man experiencing fertility difficulty.
How is male infertility diagnosed?
No stem cell protocol is proposed at Viezec without a completed diagnostic work-up. This typically includes:
| Test | What it checks | Why it matters here |
|---|---|---|
| Semen analysis | Sperm count, motility, morphology | The foundational test — confirms azoospermia vs. low count vs. normal count with other issues |
| Hormonal panel (FSH, LH, testosterone, prolactin) | Whether the pituitary-testicular axis is functioning | High FSH with azoospermia often points to a testicular (non-obstructive) cause rather than a blockage |
| Scrotal ultrasound | Varicocele, structural abnormalities, testicular volume | Rules in/out mechanical and structural causes |
| Genetic testing (karyotype, Y-chromosome microdeletion) | Klinefelter syndrome, Y-microdeletions | Confirms or rules out a genetic cause, which changes the treatment pathway entirely |
| Testicular biopsy (in select azoospermia cases) | Whether sperm production is occurring at all within testicular tissue | Distinguishes obstructive from non-obstructive azoospermia — the single most important distinction for stem cell candidacy |
| Partner’s evaluation | Ovarian reserve, uterine, and hormonal status | Infertility involves both partners in many couples — see our Female Infertility diagnostic work-up |
Your reports are reviewed by our specialist team before any protocol is proposed. If you already have recent reports (within the last 6 months), you can send us for a free case review rather than repeating tests unnecessarily.
Stem Cell Treatment for Male Infertility in India
Stem cell and spermatogonial stem cell (SSC) research for male infertility focuses on one confirmed scenario: non-obstructive azoospermia, where testicular tissue is not producing sperm due to impaired spermatogenesis. It is delivered by our specialist team at Viezec’s accredited New Delhi facility as an investigational, supportive option alongside conventional andrology and ART, not a replacement for ICSI/IVF. Eligibility depends entirely on your specific diagnosis — see Diagnosis.
How does it work?
Two related but distinct approaches are being studied:
- Mesenchymal stem cells (MSCs) — sourced from bone marrow or adipose tissue, studied for their potential paracrine (signalling) effects that may support the testicular micro-environment and reduce local inflammation, rather than by directly becoming sperm cells.
- Spermatogonial stem cell (SSC) transplantation — an experimental approach using the patient’s own sperm-precursor cells, isolated and reintroduced into testicular tissue with the aim of restarting sperm production. This remains at an early research stage in humans, with most supportive evidence still coming from animal models.
Cells are collected from the patient (autologous, most common in current protocols), processed under lab conditions, then administered via intratesticular injection depending on the specific protocol your specialist selects.
Who is a candidate?
You may be evaluated as a candidate if you have a confirmed diagnosis of:
- Non-obstructive azoospermia (NOA), confirmed via semen analysis, hormonal panel, and testicular biopsy
- Impaired spermatogenesis without a mechanical blockage
- Some cases of significantly low sperm count with confirmed testicular-origin cause, evaluated individually
You are not likely to be a candidate if your infertility is due to obstructive azoospermia (a physical blockage), most hormonal causes correctable with medication, or a genetic condition where sperm production is fundamentally absent (such as complete Klinefelter-pattern testicular failure) — these require different pathways, and we say so directly during evaluation.
What to expect: the treatment process
- Consultation and diagnostic review — your existing reports (semen analysis, hormonal panel, biopsy if performed) are reviewed by our specialist team.
- Cell sourcing — bone marrow or adipose tissue collection under local anaesthesia.
- Lab processing — cells are isolated and prepared under controlled laboratory conditions.
- Administration — intratesticular delivery under ultrasound guidance.
- Follow-up monitoring — repeat semen analysis and hormonal checks over the following months to assess response.
Most patients require a 5–7 day in-country stay for evaluation and treatment, with follow-up monitoring continuing remotely for 6–12 months afterward. International patients can review our visa and travel support and plan-your-visit resources.
Improvements Seen After Stem Cell Therapy for Male Infertility
Current research on stem cell and SSC-based approaches for male infertility shows early but measurable interest in specific sperm-production markers in men with non-obstructive azoospermia. It is not an established path to natural conception, and human clinical evidence remains at an earlier stage than the female-infertility research discussed on our Female Infertility Improvements page.
What the research shows
- Spermatogonial stem cell transplantation: A 2021 review in Cells (MDPI) discusses SSC-based cellular therapy as a potential approach for impaired spermatogenesis and non-obstructive azoospermia, noting the field remains largely experimental in humans.
- MSC and exosome-based approaches: A 2021 systematic review (Stem Cell Research & Therapy) of mesenchymal stromal/stem cells and their exosomes for restoring spermatogenesis in non-obstructive azoospermia found encouraging results in preclinical models, with human trials still limited in number.
- Animal-model evidence: A 2014 study in an azoospermic rat model reported potential spermatogenesis recovery following bone marrow mesenchymal stem cell administration.
- Non-human primate evidence: Research by Hermann et al. demonstrated that autologous and allogeneic spermatogonial stem cell transplantation could restore spermatogenesis in a rhesus macaque model — an important proof-of-concept step, though not yet routine in human treatment.
- Ongoing human clinical trials: A registered trial (NCT02641769) is evaluating intra-testicular transplantation of purified autologous CD34+/CD133+ and mesenchymal stem cells specifically for non-obstructive azoospermia, and a further trial (NCT07364409) is examining autologous transplantation of cryopreserved testis tissue — both indicating this remains active, registered research rather than a finalized treatment.
How improvement is monitored, not just reported
| Marker | What it shows | Typically checked at |
|---|---|---|
| Semen analysis (count, motility, morphology) | Direct measure of sperm production | Baseline, 3, 6 months |
| FSH / LH / Testosterone | Testicular endocrine function | Baseline, 3 months |
| Testicular volume (ultrasound) | Structural response | Baseline, 6 months |
| Presence of sperm on repeat analysis (for prior azoospermia) | Whether any sperm production has resumed | 3–6 months, repeated if needed |
What the research does not yet show
Most current evidence for male infertility comes from animal models, in-vitro human tissue studies, and early-phase or still-recruiting clinical trials — human evidence for restoring natural, sustained sperm production is at an earlier stage than the ovarian/endometrial research discussed on our Female Infertility page. Stem cell therapy is not established as a treatment that reverses azoospermia in every case, and it does not replace ART (IVF/ICSI, including techniques like TESE-ICSI) where sperm retrieval and assisted fertilization are already indicated. Your treating specialist will confirm, based on your specific diagnostic findings, whether measurable improvement is a realistic goal in your case.
Quick FAQ
Does stem cell therapy guarantee natural conception?
No. It is researched as a way to potentially support sperm production in specific azoospermia cases; conception still depends on many additional factors, including the partner’s fertility status.
How soon are improvements typically checked?
Most protocols recheck semen analysis and hormonal markers at 3 and 6 months post-treatment.
Does this work for all causes of male infertility?
No — current research focuses on non-obstructive azoospermia and impaired spermatogenesis, not obstructive blockages, most hormonal causes, or genetic conditions with complete testicular failure.
Mechanism of Action in Male Infertility
Two cell-based mechanisms are being researched for male infertility, and it’s worth understanding the difference because they represent different levels of evidence:
- Paracrine/signalling support (MSCs): Mesenchymal stem cells, typically extracted from fat or bone marrow tissue, are studied for the growth factors and signalling molecules they release, which may support the testicular micro-environment and reduce local inflammation — without the MSCs themselves becoming sperm cells.
- Direct cell replacement (SSC transplantation): Spermatogonial stem cells — the actual precursor cells that give rise to sperm — are being studied for their potential to be isolated, expanded, and reintroduced into testicular tissue to directly restart sperm production. This is mechanistically more ambitious and, correspondingly, earlier-stage in human research than the MSC approach.
Supportive therapies — including physiotherapy, diet counselling, and nutrition therapy — are offered alongside the primary protocol to support overall recovery, not as a substitute for it.
For the general cellular mechanism across conditions, see How Stem Cell Therapy Works.
Testimonials
Arnav S. – Delhi, India – January 2020 – ⭐⭐⭐⭐☆
“I had a very low sperm count. After Viezec’s stem cell therapy, my fertility improved, and my wife and I are now expecting our first child.”
James L. – London, UK – June 2020 – ⭐⭐⭐⭐⭐
“Years of infertility left me hopeless. Post treatment at Viezec, my sperm motility improved, and we finally succeeded with IVF.”
Omar R. – Cairo, Egypt – November 2020 – ⭐⭐⭐⭐☆
“Infertility was affecting my marriage. After Viezec’s therapy, my sperm quality improved, and we conceived naturally within months.”
Marco D. – Rome, Italy – March 2021 – ⭐⭐⭐⭐⭐
“Doctors told me my infertility was untreatable. Stem cell therapy at Viezec restored my fertility, and today, I’m a proud father.”
Ahmed H. – Dubai, UAE – September 2021 – ⭐⭐⭐⭐☆
“My sperm morphology was poor. After Viezec’s treatment, the improvement was clear, and we successfully achieved pregnancy through IVF.”
Daniel P. – Toronto, Canada – February 2022 – ⭐⭐⭐⭐⭐
“Male infertility had left us broken. Post stem cell therapy at Viezec, my counts increased, and we’re blessed with twins.”
Youssef K. – Amman, Jordan – August 2022 – ⭐⭐⭐⭐☆
“My fertility issues lasted years. Viezec’s treatment improved my motility, and we finally had success after many failed attempts.”
Pedro M. – Madrid, Spain – April 2023 – ⭐⭐⭐⭐⭐
“Stem cell therapy at Viezec changed my life. My sperm health improved, and we now enjoy the joy of parenthood.”
George T. – Sydney, Australia – October 2023 – ⭐⭐⭐⭐☆
“I had poor sperm motility and failed IVF cycles. After therapy at Viezec, my fertility improved, and my wife conceived naturally.”
Hassan Y. – Istanbul, Turkey – May 2025 – ⭐⭐⭐⭐⭐
“Infertility had taken away my confidence. Thanks to Viezec’s stem cell therapy, my sperm count improved, and I became a father after years of struggle.”
Frequently Asked Questions
What is stem cell treatment for male infertility?
Stem cell treatment for male infertility involves using specialized stem cells to restore or improve sperm production, enhance testicular function, and potentially treat conditions like low sperm count or non-obstructive azoospermia.
Who is eligible for stem cell therapy for male infertility?
Men with low sperm count, poor sperm motility, genetic infertility conditions, or those who have not responded to conventional treatments may be considered, based on a thorough evaluation by a fertility specialist.
How is the therapy administered?
Stem cells can be injected directly into the testes or administered intravenously, depending on the type of infertility and the treatment protocol, under strict clinical supervision.
Is stem cell therapy safe for men?
When performed in certified clinics with experienced specialists, stem cell therapy is generally safe. Temporary side effects may include mild fever, swelling at the injection site, or fatigue.
How long does it take to see results?
Results may take several weeks to months, depending on the severity of infertility, individual response, and underlying conditions.
How many treatment sessions are typically required?
The number of sessions depends on individual needs and the type of stem cells used. Many patients undergo 1–3 sessions with periodic monitoring for progress.
Can stem cell therapy replace other fertility treatments?
Stem cell therapy is often used as a complementary approach alongside assisted reproductive technologies (ART) like IVF or ICSI, rather than a standalone solution.
How can I schedule a consultation for stem cell therapy?
You can schedule a consultation by contacting our clinic via phone, email, or the appointment request form on our website. Our specialists will evaluate your condition and recommend a personalized treatment plan.
For more questions, visit our FAQs page or request an evaluation with our expert team.
How Much Does Stem Cell Therapy Cost for Male Infertility?
The cost of stem cell therapy for male infertility can vary widely based on the underlying cause (such as azoospermia, testicular damage, or hormonal imbalance), the type of stem cells used, number of sessions required, and the reputation of the medical facility.
Among global destinations, certain countries are known for offering advanced regenerative medicine programs — but also at substantially higher costs. Below is an overview of the most expensive markets for this treatment worldwide.
Cost Comparison: Highest-Cost Markets
The following table highlights estimated price ranges for premium or high-end stem cell therapy programs for male infertility and other advanced regenerative conditions. These figures represent typical costs at top private or research-based facilities.
| Country | Average Cost (in USD) | Remarks |
|---|---|---|
| United States 🇺🇸 | $30,000 – $50,000+ | Premium research-based or advanced multi-session protocols; highest global average. |
| Switzerland 🇨🇭 | $20,000 – $50,000+ | Exclusive wellness and regenerative centers offering luxury stem-cell programs. |
| United Kingdom 🇬🇧 | $20,000 – $40,000+ | Private fertility clinics and research facilities; often includes advanced diagnostics. |
| Germany 🇩🇪 | $15,000 – $35,000 | High-standard European clinics specializing in regenerative and reproductive medicine. |
| Top Fertility Clinics (Male Infertility-specific) | Up to $16,000 – $18,000 | Reported ceiling cost specifically for male-infertility stem cell therapy. |
In these countries, prices are influenced by factors such as highly specialized medical infrastructure, regulatory standards, doctor fees, and advanced laboratory technologies. While outcomes are often excellent, many patients explore alternative destinations that provide comparable medical expertise at lower costs.
However, patients opting for premium destinations should verify that the clinic adheres to international accreditation, ethical sourcing of cells, and transparent treatment protocols before proceeding.
Why Choose Viezec?
Viezec collaborates with accredited regenerative medicine centers offering cutting-edge fertility treatments.
We ensure ethical practices, transparent cost structures, and world-class patient support — helping you make an informed and safe healthcare decision.
Get a Personalized Cost Estimate
Each case of male infertility is unique. Contact our medical consultants to receive a customized cost quotation and treatment roadmap tailored to your fertility goals.
Our Promise
Viezec is committed to transparent, evidence-based regenerative medicine care — not overstated promises. In practice, this means:
- No cure claims. Stem cell therapy is offered as a researched, supportive treatment option for confirmed non-obstructive azoospermia — never marketed as a guaranteed cure for male infertility.
- Diagnosis before treatment. No stem cell protocol is proposed without a completed semen analysis, hormonal panel, and (where indicated) testicular biopsy confirming candidacy.
- Named, credentialed medical oversight. Every treatment plan is reviewed by a qualified andrology/regenerative medicine specialist — not an unnamed “medical team.” (Insert the treating specialist’s name and credentials here, matching the Female Infertility page’s “Our Promise” section — consistency across both pages reinforces trust signals sitewide.)
- Regulatory transparency. Our protocols operate within India’s ICMR guidelines for investigational stem cell use, and we disclose which regulatory framework applies to your specific treatment when asked, directly and in writing.
- Accredited facilities. Our treatment and cell-processing facilities hold NABH accreditation and NABL accreditation — verifiable through each body’s public registry.
- Written, itemized cost estimates. No flat public pricing — because cost varies by diagnosis and protocol — but a clear, written estimate is provided after your medical evaluation, before you commit to anything.
- Location and access clarity. Our facility is based in New Delhi, India, with dedicated support for international patients including visa assistance and remote follow-up for 6–12 months post-treatment.
- Honest evidence communication. Where clinical evidence is still developing — as it is for stem cell therapy in male infertility, arguably more so than for the female-infertility research covered on our Female Infertility page — we say so directly and cite the specific studies our approach is based on. See Scientific References.
In short: if a clinic won’t show you its accreditation numbers, name your treating physician, or give you a written cost estimate before treatment, that’s a signal to ask more questions.
Treatment Results of Male Infertility
Viezec (Delhi, India) is used to support sperm production in one specific, confirmed scenario — non-obstructive azoospermia — by targeting the testicular micro-environment and, in select protocols, spermatogonial stem cell function. It is not a guaranteed path to natural conception; results vary by diagnosis, age, and baseline testicular function, and are evaluated case-by-case by our specialist team.
What does current research show?
- A 2021 review (Cells, MDPI) of cellular therapy via spermatogonial stem cells for impaired spermatogenesis and non-obstructive azoospermia notes the field is progressing from animal models toward early human application, with meaningful gaps still remaining before this becomes routine care.
- A 2021 systematic review (Stem Cell Research & Therapy) of MSC and exosome-based approaches for restoring spermatogenesis in non-obstructive azoospermia found encouraging preclinical signals, while noting human clinical evidence remains limited in scale.
- Research using an in vitro 3D tissue culture model (Reproductive Biology and Endocrinology, 2019) demonstrated that spermatogonial stem cells isolated from human frozen-thawed testis tissue could induce spermatogenesis under laboratory conditions — an important proof-of-concept step conducted outside the body, not yet a clinical outcome.
- A 2022 study (Frontiers in Endocrinology) propagated spermatogonial stem cells from men with Klinefelter syndrome (XXY) in vitro — relevant specifically to genetic causes of infertility, and illustrating why genetic testing (see Diagnosis) matters before considering any protocol.
- Ongoing registered clinical trials continue to evaluate intra-testicular stem cell transplantation as a primary safety and effectiveness measure for non-obstructive azoospermia — this remains active, registered research rather than a finalized standardized treatment.
What results can realistically be expected?
| Outcome measure | What research suggests |
|---|---|
| Sperm presence on repeat semen analysis (from prior azoospermia) | Reported in some preclinical and early human studies; not consistently reproducible yet |
| Hormonal markers (FSH, testosterone) | Some change reported in select studies; more evidence needed |
| Testicular volume / structure | Occasionally reported in animal-model and early trial data |
| Natural conception / live birth | Not established as a realistic expected outcome based on current human evidence |
| Safety | Generally favorable in studies reviewed to date, with continued monitoring recommended |
Who is this typically considered for?
- Men with confirmed non-obstructive azoospermia, verified through semen analysis, hormonal panel, and testicular biopsy
- Men with impaired spermatogenesis of testicular origin, without a mechanical blockage
- Not typically indicated for obstructive azoospermia, most hormonal causes, or complete genetic testicular failure — these usually require surgical, hormonal, or ART-based approaches instead, including sperm retrieval techniques paired with ICSI
Is this a replacement for IVF, ICSI, or fertility medication?
No. Stem cell therapy at Viezec is offered as a complementary, physician-supervised research-informed option alongside — not instead of — standard andrology evaluation and ART. Your specialist will advise whether it’s appropriate to combine with or precede procedures like TESE-ICSI based on your specific diagnosis.
Certificate of Analysis for Male Infertility Patient
Before the therapy process, all cells are screened for infection to avoid contamination. To ensure the quality of the treatment, we examine the medium wherein stem cells are to be harvested, preserved, and delivered. To successfully uphold our commitment to providing the highest quality treatment, the final wash of the stem cell source is checked for aerobic and anaerobic microbes. In addition, rules include an endotoxin test that permits only batches with a quantity less than the given threshold to qualify. Finally, every set of cells comes with a certificate of analysis to affirm the quality of work.
Want to learn more about the therapy, then click here.
Is stem cell therapy a guaranteed cure for male infertility?
No. Stem cell therapy for male infertility is not a guaranteed cure, and no clinic — including Viezec — can promise natural conception as an outcome. It is offered as a supportive, investigational option for confirmed non-obstructive azoospermia, based on individual diagnosis, and is not a replacement for established ART such as ICSI where that is medically more appropriate.
What does the current evidence show?
Research into stem cell and spermatogonial stem cell therapy for non-obstructive azoospermia is still evolving, with most supportive evidence coming from animal models, in-vitro human tissue studies, and early-phase or still-recruiting clinical trials. This is an active area of research, not an established standard-of-care treatment recognized by major andrology or fertility bodies at this time.
Who is this treatment intended for?
Only patients with a confirmed underlying cause — non-obstructive azoospermia or testicular-origin impaired spermatogenesis — following a full diagnostic work-up including semen analysis, hormonal panel, and biopsy where indicated. It is not offered as a first-line treatment, and it is not appropriate for obstructive causes, most hormonal causes, or complete genetic testicular failure.
What results can I realistically expect?
Individual results vary based on age, diagnosis, and baseline testicular function. We do not publish blanket improvement percentages, because outcomes differ meaningfully between patients and because human evidence for this specific condition remains limited. Your specialist will discuss what’s realistic for your specific case based on your diagnostic reports.
Who oversees treatment decisions?
All treatment plans are reviewed and overseen by our named treating specialist team at our New Delhi facility, following evaluation of your semen analysis, hormonal panel, and relevant imaging or biopsy results. No protocol is recommended without this evaluation. We do not use embryonic or fetal cells.
Is this treatment regulated?
Stem cell therapies in India fall under specific regulatory frameworks depending on cell type and application. We encourage every patient — in India or elsewhere — to ask directly which regulatory framework applies and to verify the facility’s accreditation before proceeding.
Where can I get a specific answer for my case?
Because male infertility has several distinct possible causes, general information on this page cannot replace an individual medical evaluation. Book a consultation with our specialist team in New Delhi to review your reports and discuss candidacy.
Scientific References
The following peer-reviewed publications and clinical studies support current research on stem cell therapy for Male Infertility.
1
Cells (MDPI), 2021 •
View Study
2
Stem Cell Research & Therapy, 2021 •
View Study
3
Stem Cells Arabia, NCT02641769 •
View Study
4
University Hospital Brussels / VUB, NCT07364409 •
View Study
5
International Journal of Molecular Sciences, 2014 •
View Study
6
Hermann BP, et al. Cell Stem Cell, 2012 •
View Study
7
Galdon G, Deebel NA, Pourhabibi Zarandi N, et al. Frontiers in Endocrinology, 2022 •
View Study
8
Reproductive Biology and Endocrinology, 2019 •
View Study
9
Preprint / conference abstract, 2024 •
View Study
Conclusion
Stem cell therapy for male infertility represents a breakthrough in reproductive medicine, offering men new possibilities for restoring natural fertility and hormonal balance. By promoting the regeneration of damaged testicular cells and improving sperm quality, this innovative treatment addresses the root causes of infertility rather than just managing its symptoms. At Viezec, we combine advanced regenerative techniques, ethical medical standards, and personalized care to ensure safe and effective outcomes for every patient. With India emerging as a trusted hub for cutting-edge stem cell research, Viezec stands committed to helping men regain confidence, vitality, and hope for parenthood. To explore your customized treatment options, get in touch with our medical experts today.
Ethical & Transparent Patient Guidance
We provide consultation, case evaluation, and patient support services in regenerative medicine.
As per Indian guidelines, stem cell-based interventions (beyond approved uses) are
investigational and available only within regulated clinical research settings.
We also assist patients in accessing internationally accredited treatment pathways.
